Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000226647 | SCV000284629 | benign | Retinoblastoma | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000568995 | SCV000674713 | benign | Hereditary cancer-predisposing syndrome | 2018-06-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000568995 | SCV002530852 | benign | Hereditary cancer-predisposing syndrome | 2021-01-04 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV000226647 | SCV004846297 | benign | Retinoblastoma | 2024-09-27 | criteria provided, single submitter | clinical testing |